Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04748289Not ApplicableTerminated

ICU Cockpit Apps: Interventional Study With First ICU Cockpit Software Applications

Role: lead

NCT04746820Not ApplicableRecruiting

Functional Near-infrared Spectroscopy in Unconscious Patients

Role: lead

NCT05259514Not ApplicableTerminated

CytoSorb SAH Trial

Role: lead

NCT04418609Completed

Neuro-COVID-19: Neurological Complications of COVID-19

Role: lead

All 4 trials loaded